Measurement of surfactant phospholipids in exhaled breath condensate

P. Reinhold, M. Rothe (Jena, Berlin, Germany)

Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement
Session: Investigation, inspiration, ventilation, dedication: the essence of physiological measurement
Session type: Thematic Poster Session
Number: 4065

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Reinhold, M. Rothe (Jena, Berlin, Germany). Measurement of surfactant phospholipids in exhaled breath condensate. Eur Respir J 2008; 32: Suppl. 52, 4065

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Parameters of oxidation in exhaled breath condensate
Source: Eur Respir J 2004; 24: Suppl. 48, 470s
Year: 2004

Validation of eicosanoid measurements in exhaled breath condensate
Source: Eur Respir J 2002; 20: Suppl. 38, 422s
Year: 2002

Methodology of exhaled breath condensate
Source: Annual Congress 2009 - Noninvasive monitoring of airway inflammation: beyond exhaled nitric oxide
Year: 2009


Rapid measurement of lactate in exhaled breath condensate
Source: Eur Respir J 2006; 28: Suppl. 50, 435s
Year: 2006

Correlation of LTB4 with α-amylase in exhaled breath condensate
Source: Eur Respir J 2005; 26: Suppl. 49, 372s
Year: 2005

Separate lung exhaled breath condensate collection confirms intrapulmonary origin of exhaled breath condensate acidification
Source: Eur Respir J 2007; 30: Suppl. 51, 364s
Year: 2007

The pH-value of exhaled breath condensate - mainly influenced by exhaled volatile compounds
Source: Eur Respir J 2005; 26: Suppl. 49, 373s
Year: 2005

Exhaled breath condensate
Source: Annual Congress 2003 - PG18 - Markers of inflammation in obstructive airway disease
Year: 2003

Increased 8-isoprostane in the exhaled breath condensate of down patients
Source: Eur Respir J 2004; 24: Suppl. 48, 556s
Year: 2004

Reproducibility of exhaled breath condensate markers
Source: Eur Respir J 2008; 32:
Year: 2008


Monitoring of 24-hours variation of leukotrienes in exhaled breath condensate
Source: Annual Congress 2007 - Acute and chronic effects of air pollution
Year: 2007


Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate
Source: Eur Respir J 2006; 28: 1036-1041
Year: 2006



Endogenous and exogenous metabolites in exhaled breath condensate in asthma
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012

Exercise-induced changes in concentrations of cysteinyl-leukotrienes in exhaled breath condensate
Source: Eur Respir J 2004; 24: Suppl. 48, 680s
Year: 2004

Structures of an exhaled breath condensate in lung diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 525s
Year: 2005

Reproducibility of exhaled breath condensate pH in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 468s
Year: 2004